News

FDA Requiring Stronger Safety Labels for Opioid Medications
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced ...
US FDA names Sean Keveney as chief counsel
The U.S. Food and Drug Administration on Monday named Sean Keveney as its new chief counsel, placing him in charge of ...
Medscape22h
FDA Approves VIZZ Eye Drops to Treat Presbyopia
The FDA has approved VIZZ eye drops (LENZ Therapeutics, Inc.) for the treatment of presbyopia, the gradual loss of near ...
FDA raises recall of 64,800 lbs. of butter to second-highest warning level
Missouri-based food company Bunge North America has recalled 64,800 pounds - the equivalent of 1,800 cases - of its NH ...
FDA Issues Highest Risk Warning For Nuts
Navarro Pecan Holdings, LLC issued a voluntary recall of 32,670 pounds of pecan products on July 10 due to concerns about ...
WSJ Opinion: A Shakeup at the FDA
Jamie Lee Curtis calls out Stephen Colbert for being 'in love with' her husband Christopher Guest: 'I'm fine with it' ...
FDA Issues Nationwide Class II Recall on 32 Tons of Butter
The same butter was recalled earlier in July, but only designated as a Class III.
MedPage Today on MSN1d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season?
A separate Danish study showed that the two mRNA vaccines were also safe, with no increase in adverse events of special ...
FDA vaccine chief leaving agency after less than 3 months
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure ...
FDA's top vaccine official leaves agency after controversial decisions
Dr. Vinay Prasad, an oncologist who was a fierce critic of COVID vaccine and mask mandates, was appointed in May.
FDA’s Reversal on Gene Therapy Helps My Son
Parents of boys with Duchenne muscular dystrophy weigh in on drug innovation and medical regulation.
US FDA declines to approve Regeneron's blood cancer therapy for second time
Regeneron said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, ...